Search Results for: CLINICAL TRIALS Inconsistencies Prevalent in


- CLINICAL TRIALSInconsistencies Prevalent in Study Start-Up

Craig Morgan believes as stakeholders are increasingly aware that better study start-up (encompassing the activities associated with site identification, feasibility assessment, selection, and activation) processes are linked to shorter clinical timelines, the emphasis has been shifting in that direction.